The American Journal of Surgery
Volume 184, Issue 2 , Pages 103-113 , August 2002

Obesity and its surgical management

  • Edward H Livingston, M.D.

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-310-206-4103; fax: +1-310-206-2472
    • VAMC Greater Los Angeles Health Care System, UCLA Bariatric Surgery Program, Box 95-6904, UCLA School of Medicine, Los Angeles, CA 90095-6904, USA

Received 26 November 2001 ,Revised 3 May 2002

References 

  1. Pi-Sunyer FX. Health implications of obesity. Am J Clin Nutr. 1991;53:1595S–1603S
  2. Must A, Spadano J, Coakley EH, et al.  The disease burden associated with overweight and obesity. JAMA. 1999;282:1523–1529
  3. Allison DB, Fontaine KR, Manson JE, et al.  Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530–1538
  4. Centers for Disease Control . Healthy people 2000 (national health promotion, disease prevention objectives for the year 2000). JAMA. 1990;264:2057–2060
  5. Mokdad AH, Serdula MK, Dietz WH, et al.  The spread of the obesity epidemic in the United States, 1991-1998. JAMA. 1999;282:1519–1522
  6. Rosenbaum M, Leibel RL, Hirsch J. Obesity. N Engl J Med. 1997;337:396–407
  7. Heymsfield SB, Greenberg AS, Fujioka K, et al.  Recombinant leptin for weight loss in obese and lean adults (a randomized, controlled, dose-escalation trial). JAMA. 1999;282:1568–1575
  8. Methods for voluntary weight loss and control. Proceedings of NIH technology assessment conference, Bethesda, Maryland, 30 March–1 April 1992. Ann Intern Med. 1993;119:641–770
  9. Scott HW, Sandstead HH, Brill AB, et al.  Experience with a new technic of intestinal bypass in the treatment of morbid obesity. Ann Surg. 1971;174:560–572
  10. Griffen WO, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg. 1977;186:500–509
  11. Danish Obesity Project . Randomised trial of jejunoileal bypass versus medical treatment in morbid obesity. The Danish Obesity Project. Lancet. 1979;2:1255–1258
  12. Livingston EH, Sebastian JL, Huerta S, et al.  Biexponential model for predicting weight loss after gastric surgery for obesity. J Surg Res. 1902;101:216–224
  13. Andersen T, Backer OG, Stokholm KH, Quaade F. Randomized trial of diet and gastroplasty compared with diet alone in morbid obesity. N Engl J Med 310:352–6.
  14. Quaade F, Backer O, Stokholm KH, Andersen T. The Copenhagen PLAFA project: a randomized trial of gastroplasty versus very-low-calorie diet in the treatment of severe obesity preliminary results. Int J Obes 5:257–61.
  15. Andersen T, Stokholm KH, Backer OG, Quaade F. Long-term 5-year results after either horizontal gastroplasty or very-low-calorie diet for morbid obesity. Int J Obes. 1988;12:277–284
  16. Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg. 1987;205:613–624
  17. Sugerman HJ, Londrey GL, Kellum JM, et al.  Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg. 1989;157:93–102
  18. Sugerman HJ, Kellum JM, Engle KM, et al.  Gastric bypass for treating severe obesity. Am J Clin Nutr. 1992;55:560S–566S
  19. Sugerman HJ, Kellum JM, DeMaria EJ, Reines HD. Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity. Am J Surg. 1996;171:263–269
  20. Freeman JB, Burchett HJ. A comparison of gastric bypass and gastroplasty for morbid obesity. Surgery. 1980;88:433–444
  21. Laws HL, Piantadosi S. Superior gastric reduction procedure for morbid obesity (a prospective, randomized trial). Ann Surg. 1981;193:334–340
  22. Pories WJ, Flickinger EG, Meelheim D, et al.  The effectiveness of gastric bypass over gastric partition in morbid obesity (consequence of distal gastric and duodenal exclusion). Ann Surg. 1982;196:389–399
  23. Kim CH, Sarr MG. Severe reflux esophagitis after vertical banded gastroplasty for treatment of morbid obesity. Mayo Clin Proc. 1992;67:33–35
  24. MacLean LD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery. 1990;107:20–27
  25. MacLean LD, Rhode BM, Forse RA. A gastroplasty that avoids stapling in continuity. Surgery. 1993;113:380–388
  26. MacLean LD, Rhode BM, Sampalis J, Forse RA. Results of the surgical treatment of obesity. Am J Surg. 1993;165:155–162
  27. Wolper JC, Messmer JM, Turner MA, Sugerman HJ. Endoscopic dilation of late stomal stenosis. Its use following gastric surgery for morbid obesity. Arch Surg. 1984;119:836–837
  28. Kretzschmar CS, Hamilton JW, Wissler DW, et al.  Balloon dilation for the treatment of stomal stenosis complicating gastric surgery for morbid obesity. Surgery. 1987;102:443–446
  29. Buckwalter JA, Herbst CA, Khouri RK. Morbid obesity. Second gastric operations for poor weight loss. Am Surg. 1985;51:208–211
  30. Schwartz RW, Strodel WE, Simpson WS, Griffen WO. Gastric bypass revision (lessons learned from 920 cases). Surgery. 1988;104:806–812
  31. Naslund I. Gastric bypass versus gastroplasty. A prospective study of differences in two surgical procedures for morbid obesity. Acta Chir Scand. 1987;536(suppl):1–60
  32. Naslund I. The size of the gastric outlet and the outcome of surgery for obesity. Acta Chir Scand. 1986;152:205–210
  33. Naslund I, Wickbom G, Christoffersson E, Agren G. A prospective randomized comparison of gastric bypass and gastroplasty. Acta Chir Scand. 1986;152:681–689
  34. Hall JC, Watts JM, O’Brien PE, et al.  Gastric surgery for morbid obesity. The Adelaide study. Ann Surg. 1990;211:419–427
  35. Brolin RE, Kenler HA, Gorman JH, Cody RP. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg. 1992;215:387–395
  36. Brolin RE, LaMarca LB, Cody RP. Malabsorptive gastric bypass in patients with super obesity (a comparative study of Roux limb length). Gastroenterology. 2001;120:403
  37. Andersen T, Backer OG, Astrup A, Quaade F. Horizontal or vertical banded gastroplasty after pretreatment with very-low-calorie formula diet (a randomized trial). Int J Obes. 1987;11:295–304
  38. Andersen T, Pedersen BH, Dissing I, et al.  A randomized comparison of horizontal and vertical banded gastroplasty (what determines weight loss?). Scand J Gastroenterol. 1989;24:186–192
  39. Mathus-Vliegen EM, Tygat GN, Veldhuyzen-Offermans EA. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology. 1990;99:362–369
  40. Scopinaro N, Gianeta E, Civalleri D, et al.  Biliopancreatic bypass. In:  Griffen WO,  Printon KJ editor. Surgical management of morbid obesity. New York: Marcel Dekker; 1987;p. 93–162
  41. Pories WJ, Swanson MS, MacDonald KG, et al.  Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–350
  42. Quaranta L, Nascimbeni G, Semeraro F, Quaranta CA. Severe corneoconjunctival xerosis after biliopancreatic bypass for obesity Scopinaro’s operation. Am J Ophthalmol. 1994;118:817–818
  43. Renquist KE, Mason EE, Tang S, et al.  Pay status as a predictor of outcome in surgical treatment of obesity. Obes Surg. 1996;6:224–232
  44. Compston JE, Vedi S, Gianetta E, et al.  Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity. Gastroenterology. 1984;87:350–356
  45. Chapin BL, LeMar HJ, Knodel DH, Carter PL. Secondary hyperparathyroidism following biliopancreatic diversion. Arch Surg. 1996;131:1048–1052
  46. Noya G, Cossu ML, Coppola M, et al.  Biliopancreatic diversion for treatment of morbid obesity (experience in 50 cases). Obes Surg. 1998;8:61–66
  47. Grimm IS, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterol. 1992;87:775–779
  48. Zoli A, Altomonte L, Serra A, et al.  Undiagnosed polyarthritis with positive anti-Ro/SSA antibodies following a biliopancreatic bypass for morbid obesity. [letter] Clin Rheumatol. 1996;15:514–515
  49. Marceau P, Hould FS, Simard S, et al.  Biliopancreatic diversion with duodenal switch. World J Surg. 1998;22:947–954
  50. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8:267–282
  51. Rabkin RA. Distal gastric bypass/duodenal switch procedure, Roux-en-Y gastric bypass and biliopancreatic diversion in a community practice. Obes Surg. 1998;8:53–59
  52. Wilkinson LH, Peloso OA. Gastric (reservoir) reduction for morbid obesity. Arch Surg. 1981;116:602–605
  53. Curley SA, Weaver W, Wilkinson LH, Demarest GB. Late complications after gastric reservoir reduction with external wrap. Arch Surg. 1987;122:781–783
  54. Hoekstra SM, Lucas CE, Ledgerwood AM, Lucas WF. A comparison of the gastric bypass and the gastric wrap for morbid obesity. Surg Gynecol Obstet. 1993;176:262–266
  55. DeMaria EJ, Sugerman HJ. A critical look at laparoscopic adjustable silicone gastric banding for surgical treatment of morbid obesity (does it measure up?). Surg Endosc. 2000;14:697–699
  56. DeMaria EJ, Sugerman HJ, Meador JG, et al.  High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg. 2001;233:809–818
  57. Hauri P, Steffen R, Ricklin T, et al.  Treatment of morbid obesity with the Swedish adjustable gastric band (SAGB) (complication rate during a 12-month follow-up period). Surgery. 2000;127:484–488
  58. Miller K, Hell E. Laparoscopic adjustable gastric banding (a prospective 4-year follow-up study). Obes Surg. 1999;9:183–187
  59. Gustavsson S. Invited commentary (laparoscopic adjustable gastric banding—a caution). Surgery. 2000;127:489–490
  60. Greenstein RJ. Invited commentary (laparoscopic adjustable gastric banding—a viable option in bariatric surgery). Surgery. 2000;127:491–492
  61. Weiss HG, Nehoda H, Labeck B, et al.  Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility. Am J Surg. 2000;180:479–482
  62. Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity (technique and preliminary results of our first 400 patients). Arch Surg. 2000;135:1029–1033
  63. Schauer PR, Ikramuddin S, Gourash W, et al.  Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–529
  64. Matthews BD, Sing RF, DeLegge MH, et al.  Initial results with a stapled gastrojejunostomy for the laparoscopic isolated roux-en-Y gastric bypass. Am J Surg. 2000;179:476–481
  65. Nguyen NT, Lee SL, Goldman C, et al.  Comparison of pulmonary function and postoperative pain after laparoscopic versus open gastric bypass (a randomized trial). J Am Coll Surg. 2001;192:469–476
  66. Nguyen NT, Ho HS, Palmer LS, Wolfe BM. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 2000;191:149–155
  67. Livingston EH, Huerta S, Arthur D, et al.  Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002; In press
  68. Friedman JE, Dohm GL, Leggett-Frazier N, et al.  Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest. 1992;89:701–705
  69. Dohm GL, Tapscott EB, Pories WJ, et al.  An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J Clin Invest. 1988;82:486–494
  70. Dohm GL, Elton CW, Raju MS, et al.  IGF-I-stimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes. 1990;39:1028–1032
  71. Elton CW, Tapscott EB, Pories WJ, Dohm GL. Effect of moderate obesity on glucose transport in human muscle. Horm Metab Res. 1994;26:181–183
  72. Dohm GL, Elton CW, Friedman JE, et al.  Decreased expression of glucose transporter in muscle from insulin-resistant patients. Am J Physiol. 1991;260:E459–E463
  73. Carey JO, Azevedo JLJ, Morris PG, et al.  Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes. 1995;44:682–688
  74. Caro JF, Sinha MK, Raju SM, et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J Clin Invest. 1987;79:1330–1337
  75. Goodyear LJ, Giorgino F, Sherman LA, et al.  Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995;95:2195–2204
  76. Strollo PJ, Rogers RM. Obstructive sleep apnea. N Engl J Med. 1996;334:99–104
  77. Charuzi I, Ovnat A, Peiser J, et al.  The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome. Surgery. 1985;97:535–538
  78. Peiser J, Ovnat A, Uwyyed K, et al.  Cardiac arrhythmias during sleep in morbidly obese sleep-apneic patients before and after gastric bypass surgery. Clin Cardiol. 1985;8:519–521
  79. Charuzi I, Lavie P, Peiser J, Peled R. Bariatric surgery in morbidly obese sleep-apnea patients (short- and long-term follow-up). Am J Clin Nutr. 1992;55:594S–596S
  80. Sugerman HJ, Baron PL, Fairman RP, et al.  Hemodynamic dysfunction in obesity hypoventilation syndrome and the effects of treatment with surgically induced weight loss. Ann Surg. 1988;207:604–613
  81. Sugerman HJ, Fairman RP, Sood RK, et al.  Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr. 1992;55:597S–601S
  82. Huang Z, Willett WC, Manson JE, et al.  Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128:81–88
  83. Hall JE. Mechanisms of abnormal renal sodium handling in obesity hypertension. Am J Hypertens. 1997;10:49S–55S
  84. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31:409–414
  85. Hall JE, Summers RL, Brands MW, et al.  Resistance to metabolic actions of insulin and its role in hypertension. Am J Hypertens. 1994;7:772–788
  86. Alaud-din A, Meterissian S, Lisbona R, et al.  Assessment of cardiac function in patients who were morbidly obese. Surgery. 1990;108:809–818
  87. Alpert MA, Terry BE, Kelly DL. Effect of weight loss on cardiac chamber size, wall thickness and left ventricular function in morbid obesity. Am J Cardiol. 1985;55:783–786
  88. Carson JL, Ruddy ME, Duff AE, et al.  The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med. 1994;154:193–200 [Published erratum appears in Arch Intern Med 1994;154:1770.]
  89. Reinhold RB. Late results of gastric bypass surgery for morbid obesity. [see comments] J Am Coll Nutr. 1994;13:326–331
  90. Benotti PN, Bistrain B, Benotti JR, et al.  Heart disease and hypertension in severe obesity (the benefits of weight reduction). Am J Clin Nutr. 1992;55:586S–590S
  91. Foley EF, Benotti PN, Borlase BC, et al.  Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg. 1992;163:294–297
  92. Gonen B, Halverson JD, Schonfeld G. Lipoprotein levels in morbidly obese patients with massive, surgically-induced weight loss. Metabolism. 1983;32:492–496
  93. Gleysteen JJ, Barboriak JJ. Improvement in heart disease risk factors after gastric bypass. Arch Surg. 1983;118:681–684
  94. Gleysteen JJ. Results of surgery (long-term effects on hyperlipidemia). Am J Clin Nutr. 1992;55:591S–593S
  95. Gleysteen JJ, Barboriak JJ, Sasse EA. Sustained coronary-risk-factor reduction after gastric bypass for morbid obesity. Am J Clin Nutr. 1990;51:774–778
  96. Kelly TM, Jones SB. Changes in serum lipids after gastric bypass surgery. Lack of a relationship to weight loss. Int J Obes. 1986;10:443–452
  97. Jimenez JG, Fong B, Julien P, et al. Effect of massive obesity on low and high density lipoprotein binding to human adipocyte plasma membranes. Int J Obes 13:699–709.
  98. Jimenez JG, Fong BS, Julien P, et al. Weight loss in massive obesity: reciprocal changes in plasma HDL cholesterol and HDL binding to human adipocyte plasma membranes. Metabolism 37:580–6.
  99. Printen KJ, Scott D. Pregnancy following gastric bypass for the treatment of morbid obesity. Am Surg. 1982;48:363–365
  100. Richards DS, Miller DK, Goodman GN. Pregnancy after gastric bypass for morbid obesity. J Reprod Med 32:172–6.
  101. Rand CS, Macgregor AM. Medical care and pregnancy outcome after gastric bypass surgery for obesity. [letter] South Med J. 1989;82:1319–1320
  102. NIH Consensus Development Conference Panel . Gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115:956–961
  103. Metropolitan Life Insurance Company . 1983 Height and weight tables. Stat Bull Metrop Insur Co. 1984;64:2–9

PII: S0002-9610(02)00914-5

The American Journal of Surgery
Volume 184, Issue 2 , Pages 103-113 , August 2002

Article Tools

* Image Usage & Resolution